Molecular Partners AG (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Molecular Partners AG - ADR: Is Infosys Ltd. worth buying?
Item: Molecular Partners AG - ADR
Rating: 1.78000
Author: Trendlyne DVM scores

about

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeuti...

4.58 -0.13 (-2.76%)

36.31% Gain from 52W Low

2,076

XNAS Volume

XNAS 13 Mar, 2026 12:20 PM (EDT)

Board Meeting

The board meeting for Molecular Partners AG (ADR) is scheduled for today, for the purpose of Molecular Partners AG Annual Report for 2025 See details

Not Eligible

Expensive Valuation

13.0 / 100

Technically Neutral

58.2 / 100

1Yr Price target upside is 159%

5 analysts

Molecular Partners AG (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..